Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 13.02.2026 FDNI.LN IE00BT9PVG14 375,002.00 USD 7,370,908.72 19.656 ...
-
TalentSmartEQ’s 2026 State of EQ Report Finds Human Skills Drive Performance in AI Economy
SAN DIEGO--(BUSINESS WIRE)--World’s leading provider of emotional intelligence (EQ) solutions releases 2026 State of EQ Report...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 13.02.2026 UIGB IE00079WNSI6 8,816.00 GBP 231,776.33 26.290 ...
-
Hyatt Announces Thomas J. Pritzker Retires as Executive Chairman and Will Not Seek Re-Election to Board of Directors; Mark S. Hoplamazian Assumes Combined Role of Chairman of the Board and Chief Executive Officer
CHICAGO--(BUSINESS WIRE)--Hyatt Hotels Corporation ("Hyatt," "the Company," "we," "us," or "our") (NYSE: H) today announced that Thomas J. Pritzker, Executive Chairman of the Board of Directors, has informed the Board that he will retire as Executive Chairman, effective immediately, and will not seek re-election to the Board of Directors at Hyatt’s upcoming Annual Meeting of Stockholders in May. The Board has appointed Mark S. Hoplamazian, Hyatt’s President and Chief Executive Officer, to succe...
-
Topcon and Fixposition Announce Collaboration Agreement
LIVERMORE, Calif.--(BUSINESS WIRE)--Topcon Positioning Systems and Fixposition have entered an agreement to collaborate on integrated technology for future product offerings. “Topcon provides high-precision GNSS (global navigation satellite system) positioning technologies for geomatics, construction, and agriculture applications worldwide. Working with companies such as Fixposition — specialists in Visual RTK (real-time kinematic) and visual-aided positioning — helps create added value for our...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 13.02.2026 UNCU.LN IE00BD6GCF16 816,921.00 USD 37,330,756.12 45.697 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 13.02.2026 UINC IE00BZBW4Z27 9,819,448.00 USD 376,840,976.70 38.377 ...
-
Dialed Moods Advances Biohacking Wellness with Nature-Driven Supplement Innovation
COSTA MESA, Calif.--(BUSINESS WIRE)--Dialed Moods, a leading health and wellness company, expands its focus in 2026 on holistic biohacking through plant-powered formulations. Dialed Moods products enable individuals to integrate biohacking into their routines through clean, accessible supplements. The brand’s natural supplement offerings are designed to help consumers optimize physical performance, mental clarity and everyday vitality. Each product is crafted with carefully selected botanicals,...
-
HELLENiQ ENERGY and Chevron Sign Offshore Concession Agreements for Hydrocarbon Exploration and Production with the Hellenic Republic
ATHENS, Greece--(BUSINESS WIRE)--HELLENiQ ENERGY, in collaboration with Chevron, signed today the Lease Agreements with the Hellenic Republic for the exploration of four offshore blocks located south of Crete and the Peloponnese, marking a significant milestone for Greece’s upstream development. The successful consortium, with Chevron at 70% interest and being the Operator and HELLENiQ ENERGY at 30% interest, was selected following a competitive international tender launched by the Greek State...
-
Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, reports today its annual revenue for the fiscal year ended December 31, 2025, and provides an update on its financial position. Consolidated Revenue Poxel generated consolidat...